KalVista Pharmaceuticals ... (KALV)
KalVista Pharmaceuticals Max Pain By Strike
KALV trades at $12.89, 3.1% above the near-term max pain of $12.5 expiring Sep 19, 2025 (34 days). Price stability likely with balanced options positioning at this level. Max pain is falling across expirations ($5-$55), signaling increased put positioning or downside protection. Key magnetic zone at 13 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
KalVista Pharmaceuticals Max Pain By Expiry
Max pain for KALV shows a downward trend from 55 to 5, indicating bearish sentiment or hedging activity. The 263% spread signals divergent expectations across timeframes. Most levels below 12.89 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 12.5 | -0.39 (-3.06%) |
| Oct 17, 2025 | 12.5 | -0.39 (-3.06%) |
| Dec 19, 2025 | 10 | -2.89 (-22.45%) |
| Jan 16, 2026 | 55 | 42.11 (326.52%) |
| Mar 20, 2026 | 5 | -7.89 (-61.23%) |